ClinConnect ClinConnect Logo
Search / Trial NCT03697694

To Assess the Influence of Aronox on Parameters Associated With Aerobic Performance

Launched by NORTHUMBRIA UNIVERSITY · Oct 4, 2018

Trial Information

Current as of June 02, 2025

Completed

Keywords

ClinConnect Summary

Prior to the visit, participants will be issued with a participant information sheet to inform of the procedure and study requirements,then undergo initial screening via email or telephone to ascertain suitability to participate. If interested parties wish to participate, then an invitation for a familiarisation visit will be made, where they will:

Be provided with an overview of the protocol and given the opportunity to ask questions Complete a health and physical activity questionnaire to ascertain study suitability Complete a training status questionnaire Assessment of ability to swallo...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Healthy men 18-50 years of age
  • Not taking dietary supplement or pre workout supplements for at least 1 month prior to study start
  • Perform between 4 and 20 hours of cycling per week
  • VO2 max range ≥45 and \<70 ml/kg/min
  • Willing to participate and adhere to the study protocol
  • Willing to not change their dietary / workout habits throughout the study
  • Willing to limit berry and/or cherry intake to one portion per day
  • Able to understand the participant information, health screening questionnaire and informed consent information
  • Willing to participate and sign the informed consent form
  • Exclusion Criteria:
  • BMI \>30
  • History or current cardiometabolic, gastrointestinal or renal diseases
  • Taking any medication that might affect the outcome of the study, such as anti-inflammatory and immunosuppressant drugs.
  • Performance enhancing drugs and recreational drugs
  • Orthopedic problems that include muscle tears that might affect ability to perform exercise
  • Have a recent history of surgery that might affect physical performance
  • Smoking
  • Recent or planned change in dietary habit
  • Have lost more than 6 kg in the past 6 months or planning to lose weight in the next month
  • Allergy to berries
  • Drinking more than 2 alcoholic beverages per day on average in a week (total 14 units)

About Northumbria University

Northumbria University is a leading research-intensive institution based in the UK, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct high-quality research aimed at improving patient outcomes and informing clinical practices. With a commitment to ethical standards and regulatory compliance, Northumbria University collaborates with healthcare professionals and industry partners to explore novel therapeutic interventions and contribute to the body of evidence that shapes modern medicine.

Locations

Newcastle, Tyne & Wear, United Kingdom

Patients applied

0 patients applied

Trial Officials

Glyn Howatson

Principal Investigator

Northumbria University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials